Christopher D. Breder, MD PhD
Senior / Executive Director
Is this your profile?
Claim this listing to verify your information, add details, and be discoverable by attorneys searching for expert witnesses.
Professional Summary
Christopher D. Breder, MD PhD is a pharmaceutical research and regulation expert specializing in neurology and psychiatry litigation. With a career encompassing leadership roles in clinical development and regulatory affairs, he brings a strategic framework to his litigation work. His work centers on investigating regulatory compliance, assessing clinical trial protocols, and evaluating whether industry standards were met in drug development processes.
Dr. Breder has been retained in numerous expert witness and consulting engagements across the United States, involving cases in the pharmaceutical and biotechnology industries. His Doctor of Philosophy in Neurobiology and Doctor of Medicine, along with his Certificate Program in Pharmacoepidemiology, reinforce his ability to deliver objective, defensible analyses. He is regularly engaged by both plaintiff and defense counsel to provide clear, independent determinations of regulatory compliance and standard of care in disputes involving drug development and clinical research.
Work Experience
Christopher D. Breder, MD PhD, has over 21 years of experience in the medical and pharmaceutical fields. He is currently the Principal Manager at CIRCA-PhD LLC since August 2019. His previous roles include Head, Office of Strategic Planning & Global Head of Research and Development Center of Excellence at Sunovion Pharmaceuticals, Medical Officer to Lead Medical Officer at the Food and Drug Administration, Vice President, Clinical Development at Supernus Pharmaceuticals, and Director to Group Director, Neuroscience Global Clinical Research at Bristol-Myers Squibb Co.
Expert Intelligence
Best Descriptor
Christopher D. Breder provides expert clinical and regulatory guidance for drug development, particularly in neurology and psychiatry.
Best Use Cases
- 1consulting on clinical trial design
- 2regulatory strategy for neurological drugs
- 3expert testimony in drug development litigation
Full analysis available to registered users
View full reportEducation
Doctor of Philosophy in Neurobiology
The University of Chicago · 1992
Doctor of Medicine in Medicine
The University of Chicago, Pritzker School of Medicine · 1994
Bachelor of Science in Chemistry
The American University · 1985
Certificate Program in Pharmacoepidemiology in Pharmacoepidemiology
FDA CDER/University of Pennsylvania Program · 2010
Licenses
- Medical LicenseNew York (NY)